Powder: -20°C for 3 years | In solvent: -80°C for 1 year
KDT 501, a PPAR agonist and G protein-coupled receptor (GPR) 120 agonist, is used potentially for the treatment of type 2 diabetes.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | KDT 501, a PPAR agonist and G protein-coupled receptor (GPR) 120 agonist, is used potentially for the treatment of type 2 diabetes. |
Synonyms | KDT 501 potassium salt, KDT-501, KDT 501, Tetrahydroisohumulone |
Molecular Weight | 405.596 |
Formula | C21H34KO5 |
CAS No. | 1374259-84-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
KDT 501 potassium 1374259-84-3 KDT 501 potassium salt KDT501 KDT-501 KDT 501 Tetrahydroisohumulone inhibitor inhibit